Trial Profile
A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients With Sarcopenia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs MK 0773 (Primary)
- Indications Muscular atrophy
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 24 Dec 2014 New trial record